Quantinno Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36M Sell
574,482
-105,556
-16% -$8.44M 0.06% 396
2025
Q4
$64.8M Buy
680,038
+167,468
+33% +$16.4M 0.13% 130
2025
Q3
$50M Buy
512,570
+168,685
+49% +$17.5M 0.14% 125
2025
Q2
$36.9M Buy
343,885
+106,715
+45% +$10.8M 0.16% 92
2025
Q1
$23.9M Buy
237,170
+103,031
+77% +$10.4M 0.16% 109
2024
Q4
$12M Buy
134,139
+43,050
+47% +$3.79M 0.12% 159
2024
Q3
$7.63M Buy
91,089
+24,088
+36% +$1.9M 0.1% 208
2024
Q2
$5.16M Buy
67,001
+14,130
+27% +$1.03M 0.09% 222
2024
Q1
$3.62M Buy
52,871
+12,451
+31% +$801K 0.08% 300
2023
Q4
$2.34M Sell
40,420
-7,894
-16% -$421K 0.08% 309
2023
Q3
$2.55M Buy
48,314
+10,980
+29% +$576K 0.12% 209
2023
Q2
$2.02M Buy
37,334
+21,478
+135% +$1.12M 0.12% 217
2023
Q1
$793K Buy
15,856
+2,813
+22% +$133K 0.05% 457
2022
Q4
$603K Buy
+13,043
New +$565K 0.05% 479
2022
Q2
Sell
-8,429
Closed -$373K 610
2022
Q1
$373K Buy
+8,429
New +$365K 0.06% 380

Other funds holding BSX

Quantinno Capital Management's BSX Position: Q1 2026 in Review

Quantinno Capital Management reduced its Boston Scientific (BSX) stake by 16% in Q1 2026, selling an estimated $8.44M and leaving 574,482 shares worth $36M. The position accounts for 0.06% of the portfolio, ranked #396.

Quantinno Capital Management first reported a position in BSX in Q1 2022 and has held it in 15 quarters since. The position peaked at $64.8M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Quantinno Capital Management held 574,482 shares of Boston Scientific worth $36M as of Q1 2026.
  • Quantinno Capital Management sold 105,556 Boston Scientific shares in Q1 2026, an estimated $8.44M.
  • Boston Scientific made up 0.06% of Quantinno Capital Management's portfolio in Q1 2026, its #396 holding.
  • Quantinno Capital Management first reported a position in Boston Scientific in Q1 2022 and has held it in 15 quarters since.
  • Quantinno Capital Management's Boston Scientific position peaked at $64.8M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.